ILA ISLAND PHARMACEUTICALS LTD

EQS-News: Island Pharmaceuticals targets Mosquito-borne viruses with antiviral pipeline

EQS-News: Island Pharmaceuticals Ltd
Island Pharmaceuticals targets Mosquito-borne viruses with antiviral pipeline

21.12.2022 / 20:30 CET/CEST
The issuer is solely responsible for the content of this announcement.


Contact Details

Proactive Investors

Jonathan Jackson


News Source: News Direct


21.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Island Pharmaceuticals Ltd
United States
ISIN: AU0000138869
EQS News ID: 1519411

 
End of News EQS News Service

1519411  21.12.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1519411&application_name=news&site_id=research_pool
EN
21/12/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ISLAND PHARMACEUTICALS LTD

 PRESS RELEASE

EQS-News: Island Pharmaceuticals targets Mosquito-borne viruses with a...

EQS-News: Island Pharmaceuticals Ltd Island Pharmaceuticals targets Mosquito-borne viruses with antiviral pipeline 21.12.2022 / 20:30 CET/CEST The issuer is solely responsible for the content of this announcement. Contact DetailsProactive InvestorsJonathan Jackson News Source: News Direct 21.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Re...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch